XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.4
Note 12 - Stockholders' Equity (Tables)
12 Months Ended
Sep. 30, 2024
Notes Tables  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
  Year Ended September 30, 
  

2024

  

2023

 

Cost of revenue

 $-  $7 

Operating expenses

  505   395 

Interest expense and other, net

  53   169 

Total

 $558  $571 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Type

 

Issue Date

 

Shares

  

Price

 

Expiration

Financing (Montage)

 

10/10/2017

  1,327  $132.50 

10/10/2025

Placement Agent

 

2/4/2021

  31,564  $3.88 

2/4/2026

Investors

 

5/14/2021

  592,106  $2.51 

11/16/2026

Placement Agent

 

5/14/2021

  179,536  $2.85 

5/12/2026

Total

    804,533      
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
  

2024

  

2023

 
  

Board

  

Non-Board

  

Board

  

Non-Board

 

Weighted-average fair value per share option

 $0.67  $0.67  $0.84  $0.90 

Expected life (in years)

  5.8   5.0   5.0   5.8 

Volatility

  108.5%  96.1%  88.5%  90.7%

Risk-free interest rate

  4.0%  4.2%  4.1%  4.0%

Dividend yield

  0.0%  0.0%  0.0%  0.0%
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Restricted Stock

  

Stock Options

  

Stock Warrants

 
          

Weighted Average

      

Weighted Average

 
  

Awards

  

Awards

  

Exercise Price

  

Warrants

  

Exercise Price

 

Outstanding, October 1, 2022

  200,000   1,157,927  $3.49   1,757,629  $3.64 

Granted

  -   702,000   1.19   -   - 

Exercised

  -   -   -   -   - 

Forfeited

  -   (28,348)  2.49   -   - 

Expired

  -   (64)  1,873.44   -   - 

Outstanding, September 30, 2023

  200,000   1,831,515  $2.56   1,757,629  $3.64 

Granted

  -   330,000   0.83   -   - 

Exercised

  -   -   -   -   - 

Forfeited

  -   (53,518)  1.50   -   - 

Expired

  -   (102)  1,413.97   (953,096)  2.85 

Outstanding, September 30, 2024

  200,000   2,107,895  $2.25   804,533  $2.85 
Schedule of Nonvested Share Activity [Table Text Block]
      

Weighted Average

 
      

Grant-Date

 
  

Shares

  

Fair Value

 

Unvested at October 1, 2023

  683,418  $1.10 

Granted

  330,000   0.67 

Vested

  (436,413)  1.06 

Forfeited/Cancelled

  (13,000)  1.07 

Unvested at September 30, 2024

  564,005  $0.88 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

Exercise Price

 

Number of Options

  

Weighted Average Remaining Contractual Life (Years)

  

Weighted Average Exercise Price

  Aggregate Intrinsic Value 

Options outstanding

  2,107,895   7.7  $2.25  $105,000 

Options exercisable

  1,543,890   7.3  $2.66  $34,166